Ergänzende Studien zum KSP-Markerimpfstoff CP7_E2alf
Julia Henke(Friedrich-Loeffler-Institut), Sandra Blome(Friedrich-Loeffler-Institut), Theresa Schwaiger(University of Graz), Martin Beer(Institute of Virology of the Slovak Academy of Sciences), Simone Leidenberger(Friedrich-Loeffler-Institut), Jolene Carlson(Friedrich-Loeffler-Institut), Jens P. Teifke(Friedrich-Loeffler-Institut), L. Zani(Twitter (United States)), Charlotte Schröder(Friedrich-Loeffler-Institut), Kore Schlottau(Friedrich-Loeffler-Institut)
Unknown
November 30, 2017
Cited by 0
Related Papers
The evolution of SARS-CoV-2
|Nature Reviews Microbiology|2023|1.2k
Taxonomy of the order Bunyavirales: update 2019
|Archives of Virology|2019|405